# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# Analysis 1.14. Comparison 1: Fecal microbiota transplantation (FMT) versus control for induction of remission in ulcerative colitis (UC), Outcome 14: Serious adverse events for induction of remission in UC: subgroup analysis by age

|Study or Subgroup|FMT Events|FMT Total|Control Events|Control Total|Weight|Risk Ratio M-H, Random, 95% CI|Risk Ratio M-H, Random, 95% CI|
|---|---|---|---|---|---|---|---|
|1.14.1 Children|5|13|1|12|12.2%|4.62 [0.63 , 34.05]| |
|Subtotal (95% CI)| |13| |12|12.2%|4.62 [0.63 , 34.05]| |
|Total events:|5| |1| | | | |
|Heterogeneity:|Not applicable|Not applicable|Not applicable|Not applicable|Not applicable|Not applicable|Not applicable|
|Test for overall effect:|Z = 1.50 (P = 0.13)|Z = 1.50 (P = 0.13)|Z = 1.50 (P = 0.13)|Z = 1.50 (P = 0.13)|Z = 1.50 (P = 0.13)|Z = 1.50 (P = 0.13)|Z = 1.50 (P = 0.13)|
|1.14.2 Adults|4|23|1|22|10.9%|3.83 [0.46 , 31.62]| |
|Březina 2021|3|38|2|35|16.3%|1.38 [0.25 , 7.79]| |
|Costello 2019|1|7|1|8|7.3%|1.14 [0.09 , 15.08]| |
|Fang 2021|0|10|0|10| |Not estimable| |
|Haifer 2022|2|15|2|20|14.4%|1.33 [0.21 , 8.41]| |
|Moayyedi 2015|3|38|2|37|16.3%|1.46 [0.26 , 8.25]| |
|Paramsothy 2017|2|41|1|40|8.7%|1.95 [0.18 , 20.68]| |
|Rossen 2015|2|23|2|25|13.8%|1.09 [0.17 , 7.10]| |
|Sarbagili Shabat 2022|0|36|0|15| |Not estimable| |
|Subtotal (95% CI)| |231| |212|87.8%|1.55 [0.73 , 3.26]| |
|Total events:|17| |11| | | | |
|Heterogeneity:|Tau² = 0.00; Chi² = 0.99, df = 6 (P = 0.99); I² = 0%|Tau² = 0.00; Chi² = 0.99, df = 6 (P = 0.99); I² = 0%|Tau² = 0.00; Chi² = 0.99, df = 6 (P = 0.99); I² = 0%|Tau² = 0.00; Chi² = 0.99, df = 6 (P = 0.99); I² = 0%|Tau² = 0.00; Chi² = 0.99, df = 6 (P = 0.99); I² = 0%|Tau² = 0.00; Chi² = 0.99, df = 6 (P = 0.99); I² = 0%|Tau² = 0.00; Chi² = 0.99, df = 6 (P = 0.99); I² = 0%|
|Test for overall effect:|Z = 1.14 (P = 0.25)|Z = 1.14 (P = 0.25)|Z = 1.14 (P = 0.25)|Z = 1.14 (P = 0.25)|Z = 1.14 (P = 0.25)|Z = 1.14 (P = 0.25)|Z = 1.14 (P = 0.25)|
|Total (95% CI)| |244| |224|100.0%|1.77 [0.88 , 3.55]| |
|Total events:|22| |12| | | | |
|Heterogeneity:|Tau² = 0.00; Chi² = 2.01, df = 7 (P = 0.96); I² = 0%|Tau² = 0.00; Chi² = 2.01, df = 7 (P = 0.96); I² = 0%|Tau² = 0.00; Chi² = 2.01, df = 7 (P = 0.96); I² = 0%|Tau² = 0.00; Chi² = 2.01, df = 7 (P = 0.96); I² = 0%|Tau² = 0.00; Chi² = 2.01, df = 7 (P = 0.96); I² = 0%|Tau² = 0.00; Chi² = 2.01, df = 7 (P = 0.96); I² = 0%|Tau² = 0.00; Chi² = 2.01, df = 7 (P = 0.96); I² = 0%|
|Test for overall effect:|Z = 1.60 (P = 0.11)|Z = 1.60 (P = 0.11)|Z = 1.60 (P = 0.11)|Z = 1.60 (P = 0.11)|Z = 1.60 (P = 0.11)|Z = 1.60 (P = 0.11)|Z = 1.60 (P = 0.11)|
|Test for subgroup differences:|Chi² = 1.01, df = 1 (P = 0.31), I² = 1.1%|Chi² = 1.01, df = 1 (P = 0.31), I² = 1.1%|Chi² = 1.01, df = 1 (P = 0.31), I² = 1.1%|Chi² = 1.01, df = 1 (P = 0.31), I² = 1.1%|Chi² = 1.01, df = 1 (P = 0.31), I² = 1.1%|Chi² = 1.01, df = 1 (P = 0.31), I² = 1.1%|Chi² = 1.01, df = 1 (P = 0.31), I² = 1.1%|

Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.